@myesmo.bsky.social
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
@dyrskjot.bsky.social @niklaskluemper.bsky.social
03.03.2026 10:04 — 👍 0 🔁 0 💬 0 📌 0
🌐Join this #ESMODeepDive to refine treatment sequencing, manage variant histologies, and apply biomarker‑driven care.
Live Q&A 💬 ESMO member: register to secure your seat:
🔗 https://ow.ly/E5qk50YoqoX
Live viewers earn 2 ESMO‑MORA Category 1 points
#ESMOWebinar #ESMOOnAir
⏳ Early fee ends 28 Apr.
📝 #ESMOExamination 2026 is on 24 Oct (13:00–15:30 CEST) — main session onsite in Madrid + parallel sessions in selected locations.
🔗 Secure your seat: https://ow.ly/Rxub50YnZiW
📣 #ESMO26: Global collaboration starts here. Submit your abstract and engage with the full spectrum of innovation—from basic science to clinical development. Deadline 12 May 2026
🔗 https://ow.ly/IfQE50YmOWt
#esmomeetings
📹 Another inspiring Diary of an Oncology Leader episode is here: Erika Ruiz shares insights on how #empathy and #adaptability shape #ProfessionalGrowth. Jarushka Naidoo
🔗 https://ow.ly/witW50YlJRn
#ESMOW4O #W4O
📣 ESMO Oncogene-addicted mNSCLC Living Guideline v1.3 update: New algorithms and recommendations for c-Met overexpression, NRG1 gene fusion, EGFR mutations and HER2 alterations.
🔗 https://ow.ly/82yx50YmhtR
#ClinicalPracticeGuideline
Why are older adults still not properly considered in #ClinicalResearch? In the #ESMODailyReporter, Anna Mislang & Capucine Baldini highlight key barriers and stress the need to integrate #QoL, functional independence and patient priorities in trial design.
➡️ https://ow.ly/vG6J50YmlfO
📣 #ESMOBreast26: Get inspired and be part of the conversation shaping the future of breast cancer treatment and care. Last chance to register and save!
⏰ Deadline 26 February 2026
🔗 https://ow.ly/8RGA50YlJQm
#esmomeetings
The next #ESMOGuidelines webinar focuses on #GastroesophagealCancer — from biomarker testing to immunotherapy integration.
🎙 Live Q&A with expert faculty
🎓 Earn 1 ESMO-MORA Cat. 1 point
🆓 Open to all with an ESMO account
🔗 Join us: https://ow.ly/SU2g50YlJnP
#ESMOOnAir #ESMOWebinars
Unlocking unstructured #EMR data is key to understanding cancer trajectories.
A study in ESMO Real World Data & Digital Oncology shows how #NLP can extract #ClinicalInsights from narrative clinical documentation.
Read Rodrigo Dienstmann in the #ESMODailyReporter
➡️ https://ow.ly/LC2o50YkRYS
📣 #ELCC26: innovation meets collaboration.
🎥 Hear López‑Ríos on key trends (earlier biomarkers, AI, predictive biomarkers for ADCs) and Leighl on the value of networking & data‑sharing at ELCC.
🔗 Preferential rates end 25 Feb: https://ow.ly/7nlg50YkTgS
#esmomeetings
#ICHNO26 🔔 Late registration closes tomorrow! Register by 25 Feb
🔗 https://ow.ly/2B4j50YkRvi
Get randomised trial updates, expert debate and practical takeaways — plus multidisciplinary exchange.
📍 Seville | 19–21 Mar 2026
#HeadAndNeckOncology #esmomeetings
@siogorg.bsky.social
23.02.2026 09:27 — 👍 1 🔁 0 💬 0 📌 0
ESMO and SIOG publish a joint paper on improving clinical trial designs for #OlderAdults with cancer. Key points: include older adults, engage patients/caregivers, use adaptive designs & integrate geriatric assessment.
Read the full paper: https://ow.ly/8QGn50Yk5jP
#GeriOnc
➡️ New ESMO Living Guideline on Local and Locoregional Prostate Cancer. Consult all recommendations & algorithms from the recent #ClinicalPracticeGuideline in an interactive format, also mobile friendly.
🔗 https://ow.ly/zi8P50YhZy5
📣 #ESMOBreast26: The place to gain exclusive insights into the latest advancements in breast cancer treatment and care.
⏰ Last days to benefit from big savings! Deadline 26 February 2026
🔗 https://ow.ly/bvt450YccxW
#esmomeetings
Prof. Florian Lordick, ESMO GI 2026 Scientific Committee member, invites you to Munich — onsite or online — for a key GI oncology meeting of the year.
🗓️ 1–4 July 2026
⏰ Early reg: 15 April
👉 Register now: https://ow.ly/FtGR50YcGIt
#ESMOGI26 #esmomeetings
👉 Stay ahead of emerging #toxicity challenges in next‑gen #immunotherapies. Get insights from experts and join the live Q&A.
🔗 Register now and earn 1 ESMO-MORA point: https://ow.ly/HMns50YcO6k
#ESMOOnAir #ESMOWebinars
👉 Prof. David Thomas, Sydney, Australia, ESMO Sarcoma and Rare Cancers 2026 Scientific Co-Chair, invites you to join a gathering where rare cancers research comes together to drive real-world impact. Register now!
🔗 https://ow.ly/PCAR50Yclm5
#ESMORareCancers26 #esmomeetings
🎥 Hear Jarushka Naidoo on why #ELCC26 is an intimate meeting where young oncologists meet experts, ask questions & build mentorships.
⏳ Late registration ends 25 Feb. Secure your seat (onsite in Copenhagen & online): 🔗 https://ow.ly/GMof50YcHbj
#LungCancer #esmomeetings
#ICHNO26 🔔 Late registration is still open!
Register by 25 Feb
🔗 https://ow.ly/ALal50YbKWf
Strengthen clinical decision-making with cutting-edge science, randomised trial updates & multidisciplinary expert exchange
📍 Seville | 19–21 March 2026
#HeadAndNeckOncology #esmomeetings
📣#ESMOGynae26: From breakthroughs in ovarian cancer therapies to new hope for rare tumours, every session is designed to bring us closer to better outcomes, earlier diagnoses, and more personalised care
⏰Share your research by 31 March 2026
#esmomeetings
🔗 https://ow.ly/MhOS50Y9XcE
📣ESMO #ClinicalPracticeGuideline on #Lymphomas - New Living Guideline recommendations in the relapsed/refractory setting:
- Epcoritamab combinations and odronextamab in Follicular Lymphoma
- Sonrotoclax in Mantle Cell Lymphoma thrid-line or later
🔗 https://ow.ly/v7Uo50YcbSE
📣 #ESMO26: Secure your stay and join us in Madrid, Spain, from 23 to 27 October 2026.
#esmomeetings
🔗 https://ow.ly/LPq250Y9Trc
📣Updated ESMO #ClinicalPracticeGuideline on advanced and metastatic #ProstateCancer:
✅ Substantial advances in castration-sensitive & -resistant prostate cancer
✅ Updated algorithms & recommendations reflecting latest clinical data
#ESMOGuidelines Christopher Sweeney
🔗 https://ow.ly/E4ov50Yc8e2
📣 #ESMO26: Where the world of oncology meets and the future of cancer care takes shape. Abstract submission system now open!
⏰Deadline 12 May 2026
👉 Share your groundbreaking research
- Gain global recognition
- Present LIVE in Madrid
#esmomeetings
🔗 https://ow.ly/utHu50Y9bHC
👉 From data to impact.
Discover how your abstract can help shape progress in GI cancer care at ESMO GI 2026, Munich, 1–4 July 2026.
#ESMOGI26 #esmomeetings
SUBMIT YOUR ABSTRACT NOW!
🔗 https://ow.ly/HQLX50Y8NgY
⏰ Still time to save on #ELCC26 registration. Reduced fees available until 25 Feb
Join the thoracic oncology community in Copenhagen and online, 25–28 March. Secure your seat
🔗 https://ow.ly/TBOQ50Y8Oe6
New evidence, case‑based insights & multidisciplinary exchange
#esmomeetings
👉 Prof. Eva Tiensuu Janson, Uppsala, Sweden, ESMO Sarcoma and Rare Cancers 2026 Scientific Co-Chair, invites you to meet peers and experts shaping the future of rare cancer care. ⏰ Register by 11 Feb and save! #ESMORareCancers26 #esmomeetings
🔗 https://ow.ly/xX5150Y5hzj
On #WorldCancerDay, ESMO joins the global call to place people at the centre of #CancerCare, promoting patient-centred oncology adjusted to the individual characteristics of each person - a vision at the core of the ESMO Roadmap 2030. #UnitedByUnique
📌 https://ow.ly/YBUW50Y8E3k
